 "Sebi proposes alternate mechanism to delist shares from stock exchanges")
India's market regulator on Monday proposed an alternate mechanism by which companies could delist their shares from stock exchanges, according to a consultation paper released on the regulator's website.
The Securities and Exchange Board of India (SEBI) said companies could offer their public shareholders fixed prices for the shares being delisted.
Currently, delisting occurs via reverse book-building, a process wherein shareholders place offers for the price at which they are willing to sell securities back to the promoters, who are large shareholders who can influence company policy.
In addition, SEBI suggested a framework for companies that have shares held by investment-holding companies.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app